UBS Group »

Atara Biotherapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.9M 3.7M 0.51
2023-09-30 $87k 59k 1.48
2023-06-30 $83k 51k 1.61
2023-03-31 $1.0M 335k 3.00
2022-12-31 $1.2M 355k 3.28
2022-09-30 $425k 86k 4.95
2022-06-30 $338k 41k 8.29
2022-03-31 $2.3M 249k 9.26
2021-12-31 $3.9M 246k 15.77
2021-09-30 $2.4M 135k 17.90
2021-06-30 $494k 32k 15.53
2021-03-31 $1.5M 103k 14.36
2020-12-31 $65k 3.3k 19.69
2020-09-30 $49k 3.8k 12.85
2020-06-30 $72k 5.0k 14.38
2020-03-31 $85k 10k 8.49
2019-12-31 $622k 38k 16.49
2019-09-30 $0 44k 0.00
2019-06-30 $70k 3.5k 19.89
2019-03-31 $66k 1.7k 40.00
2018-12-31 $80k 2.3k 34.52
2018-09-30 $0 18k 0.00
2018-06-30 $30k 820 36.59
2018-03-31 $4.0M 103k 39.02
2017-12-31 $23k 1.3k 18.03
2017-09-30 $17k 1.1k 16.33
2017-06-30 $0 20 0.00
2017-03-31 $0 17 0.00
2016-12-31 $120k 8.4k 14.25
2016-09-30 $147k 6.9k 21.33
2016-06-30 $166k 7.5k 22.06
2016-03-31 $141k 7.2k 19.61
2015-12-31 $925k 35k 26.39
2015-09-30 $116k 3.7k 31.61
2015-03-31 $42k 1.0k 42.00